Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 20/20 | 0.83 |
| ▸ | MMP2 | P08253 | 19/20 | 0.83 |
| ▸ | MMP8 | P22894 | 18/20 | 0.83 |
| ▸ | MMP3 | P08254 | 5/20 | 0.83 |
| ▸ | MMP9 | P14780 | 12/20 | 0.79 |
| ▸ | MMP1 | P03956 | 6/20 | 0.70 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.70 |
| ▸ | MMP14 | P50281 | 3/20 | 0.61 |
| ▸ | MMP7 | P09237 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8332783 | 0.91 | MMP13 (0.80) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL6363229 | 0.91 | MMP13 (1.00) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8334439 | 0.87 | MMP13 (0.69) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8334433 | 0.87 | MMP13 (0.80) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8321368 | 0.83 | MMP13 (0.76) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8326831 | 0.82 | MMP13 (0.75) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL14340694 | 0.81 | MMP13 (0.76) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8326911 | 0.81 | MMP13 (1.00) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL14340672 | 0.81 | MMP13 (0.67) | MMP13MMP2MMP8MMP3MMP9 | |
| SCHEMBL8332819 | 0.81 | MMP13 (0.61) | MMP13MMP2MMP8MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004043943-A1 | AROMATIC SULFONE HYDROXAMIC ACIDS AND THEIR USE AS PROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |